Drug intelligence / Profile preview

gynostemma pentaphyllum total glycoside granules

Development stage
Unknown
Lead developer
Changzhou Sports Hospital
Administration
Oral
01

Overview

Gynostemma pentaphyllum total glycoside granules are a botanical drug product derived from the herb *Gynostemma pentaphyllum* (Jiaogulan). The primary active components are gypenosides, which are dammarane-type saponins structurally similar to ginsenosides. These glycosides are known to activate adenosine monophosphate-activated protein kinase (AMPK), a key regulator of lipid and glucose metabolism. In clinical settings, particularly in China, it is used to treat dyslipidemia and non-alcoholic fatty liver disease (NAFLD) by lowering non-HDL cholesterol and triglycerides while improving cardiovascular function. The granule formulation is intended for oral administration and is often studied in combination with lifestyle interventions like scientific exercise.

Other names
GypenosidesGynostemma pentaphyllum total saponinsJiaogulan total glycoside granules
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)KATP channel (ATP-sensitive potassium channel)FOXO1 (Forkhead box protein O1)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)NF-κBPPARGC1A (Peroxisome proliferator–activated receptor gamma coactivator 1-alpha)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)mTOR (Mammalian target of rapamycin kinase)RK (Ribokinase)

Beyond the preview

Go deeper on gynostemma pentaphyllum total glycoside granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gynostemma pentaphyllum total glycoside granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call